SIGA Technologies
SIGA
$9.32
Share price
6.09%
Change (1 day)
60.05%
Change (1 year)
Categories
SIGA Technologies (SIGA) - P/B ratio
P/B ratio as of May 2024 : 3.17
According to SIGA Technologies's latest financial reports the company has a price-to-book ratio of 3.17.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
SIGA Technologies - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.02 | -35.97% |
| 2022-12-31 | 3.16 | -1.22% |
| 2021-12-31 | 3.20 | -26.25% |
| 2020-12-31 | 4.34 | 9.62% |
| 2019-12-31 | 3.95 | -35.86% |
| 2018-12-31 | 6.17 | -620.66% |
| 2017-12-31 | -1.18 | 117.73% |
| 2016-12-31 | -0.5439 | 580.71% |
| 2015-12-31 | -0.0799 | -74.43% |
| 2014-12-31 | -0.3126 | -103.06% |
| 2013-12-31 | 10.2 | 113.55% |
| 2012-12-31 | 4.79 | 50.74% |
| 2011-12-31 | 3.18 | -94.41% |
| 2010-12-31 | 56.9 | 62.85% |
| 2009-12-31 | 34.9 | -53.04% |
| 2008-12-31 | 74.4 | 271.94% |
| 2007-12-31 | 20.0 | 15.92% |
| 2006-12-31 | 17.2 | 121.35% |
| 2005-12-31 | 7.79 | -12.65% |
| 2004-12-31 | 8.92 | 15.78% |
| 2003-12-31 | 7.70 | -9.25% |
| 2002-12-31 | 8.49 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | 13.9 | 339.12% | 🇺🇸 USA |
 Novavax NVAX | -0.8453 | -126.65% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | 5.75 | 81.17% | 🇺🇸 USA |
 NanoViricides NNVC | 1.14 | -64.21% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -1.87 | -158.97% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | 0.1517 | -95.22% | 🇺🇸 USA |